What’s the deal with Alzheimer’s disease and amyloid? - Ars Technica

What’s the deal with Alzheimer’s disease and amyloid?  Ars Technica'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests  BBCNew Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes  U.S. News & World ReportEffect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes  The GuardianAnti-amyloid Alzheimer’s drugs show no clinically meaningful effect  Cochrane Collaboration